A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to ...

The Korea Research Institute of Standards and Science has successfully developed a nanomaterial capable of simultaneously ...

A new nanoparticle capable of carrying much higher doses of drugs while staying stable for extended periods could make ...

The acquisition will expand AbbVie's exploration of in vivo CAR-T therapy, an ambitious approach that could sidestep some of ...

ACROBiosystems has developed a series of specialized proteases for the screening and validation of ADC linkers, focusing on ...

There's a long way to go when it comes to sex and gender equity in medicine, but engineers at The University of New Mexico hope to close the gap with ...

Everest Medicines (HKEX: 1952.HK), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines, recently hosted the "2025 ...

A Nigerian biomedical researcher, Ibrahim Oladele, is developing an innovative drug delivery system that could significantly ...

For the millions of Americans battling autoimmune disorders, new hope may be on the horizon in the form of reverse or inverse ...

AbbVie’s $2.1 billion acquisition of Capstan Therapeutics aims to advance in vivo CAR-T therapies, transforming autoimmune ...

U.S. drugmaker AbbVie said on Monday it will acquire cell therapy developer Capstan Therapeutics in a cash deal worth up to ...